Virtu Financial LLC Catalyst Biosciences, Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$0.2 - $0.35 $9,726 - $17,021	48,633 New	48,633 $17,000
Q4 2022 Feb 15, 2023	SELL	$0.49 - $0.57 $28,398 - $33,035	-57,957 Reduced 30.64%	131,218 $69,000
Q3 2022 Nov 07, 2022	BUY	$0.49 - $1.95 $66,247 - $263,636	135,198 Added 250.47%	189,175 $95,000
Q2 2022 Aug 09, 2022	BUY	$0.36 - $1.78 $19,431 - $96,079	53,977 New	53,977 $96,000
Q1 2022 May 17, 2022	SELL	$0.51 - $1.0 $24,194 - $47,441	-47,441 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$0.91 - $4.16 $16,687 - $76,286	18,338 Added 63.01%	47,441 $43,000
Q3 2021 Nov 12, 2021	BUY	$3.78 - $5.18 $26,860 - $36,809	7,106 Added 32.3%	29,103 $120,000
Q1 2018 May 14, 2018	BUY	$14.18 - $35.6 $311,917 - $783,093	21,997 New	21,997 $568,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.